Skip to Content

Direxion Moonshot Innovators ETF MOON

Medalist Rating as of | See Direxion Investment Hub

Morningstar’s Analysis MOON

Will MOON outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Direxion Moonshot Innovators ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MOON

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 37.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Avidity Biosciences Inc Ordinary Shares

7.04 1.6 Mil
Healthcare

4D Molecular Therapeutics Inc Ordinary Shares

4.28 970,787
Healthcare

Coinbase Global Inc Ordinary Shares - Class A

4.23 958,425
Financial Services

Robinhood Markets Inc Class A

3.69 837,114
Financial Services

Allogene Therapeutics Inc

3.44 779,296
Healthcare

Rumble Inc

3.21 727,450
Technology

Squarespace Inc Class A

3.00 680,940
Technology

Aurora Innovation Inc Class A

2.88 652,528
Technology

Couchbase Inc

2.87 649,857
Technology

Recursion Pharmaceuticals Inc Class A

2.63 595,041
Healthcare